U.S. Supreme Court

Case Status


Docket Number


Cert. Denied


Questions Presented

Whether, for purposes of standing under Article III, a plaintiff’s speculation that he might have paid less for treatment if a pharmaceutical product were packaged differently is sufficient to establish an economic injury in fact.

Case Updates

Cert. petition denied

May 21, 2018

U.S. Chamber urges Supreme Court to review whether plaintiffs have standing to pursue class action alleging that prescription eye drops dispensed too much medication

April 23, 2018

Click here to view the amicus brief filed jointly by the U.S. Chamber, American Tort Reform Association, National Association of Manufacturers, and Pharmaceutical Research and Manufacturers of America.

Jeffrey S. Bucholtz and Paul Alessio Mezzina of King & Spalding LLP served as co-counsel for the amici.

Case Documents